U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07759427) titled 'Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia' on July 15.
Brief Summary: Ventricular tachycardia (VT) is an abnormal and dangerous heart rhythm affecting the lower chambers of the heart (the ventricles). Patients with structural heart disease caused by previous heart attacks are at an increased risk of developing VT. Current guidelines recommend that patients who develop this abnormal heart rhythm are considered for invasive catheter ablation (ICA). This is an invasive procedure where specialised catheters and a 3D electro anatomical mapping (EAM) system are used to identify the region of ...